株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

光学前臨床画像の世界市場:市場規模、シェア、動向分析、予測 - 製品タイプ 別、最終用途別、地域別(2020年-2027年)

Optical Preclinical Imaging Market Size, Share & Trends Analysis Report By Product Type (Device, Consumables, Software), By End Use, By Region, And Segment Forecasts, 2020 - 2027

発行 Grand View Research, Inc. 商品コード 935375
出版日 ページ情報 英文 36 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.09円で換算しております。
光学前臨床画像の世界市場:市場規模、シェア、動向分析、予測 - 製品タイプ 別、最終用途別、地域別(2020年-2027年) Optical Preclinical Imaging Market Size, Share & Trends Analysis Report By Product Type (Device, Consumables, Software), By End Use, By Region, And Segment Forecasts, 2020 - 2027
出版日: 2020年04月16日 ページ情報: 英文 36 Pages
概要

世界の光学的前臨床画像の市場規模は、2027年末までに5億4,300万米ドルに達し、3.3%のCAGRで拡大すると予測されています。さまざまな疾患に対する効果的な治療法を研究、開発することを目的とした前臨床研究の数の増加は、光学的前臨床画像システムの採用を後押しする主要な要因です。

当レポートは、世界の光学的前臨床画像市場を調査したもので、市場の概要と動向、製品タイプ別、最終用途別、地域別の分析や予測、競合情勢などの情報を提供しています。

目次

第1章 調査手法と範囲

  • 市場区分と範囲
  • 調査手法
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • 二次情報源のリスト
  • 主要情報源のリスト
  • 目的

第2章 エグゼクティブサマリー

  • 市場の見通し
  • セグメントの見通し
  • 競合考察

第3章 市場変数、市場動向、範囲

  • 市場系統の見通し
  • 浸透と成長の見通しマッピング
  • 業界のバリューチェーン分析
  • 市場力学
  • 光学前臨床画像分析ツール

第4章 光学前臨床画像市場の予測と動向分析: 製品タイプ別

  • 定義と範囲
  • 端末
    • 蛍光
    • 生物発光
  • 消耗品
    • 蛍光
    • 生物発光
  • ソフトウェア
  • 製品タイプ別市場シェア
  • セグメントダッシュボード
  • 製品タイプ別の市場展望
    • 端末
    • 消耗品
    • ソフトウェア

第5章 光学前臨床画像市場の予測と動向分析:最終用途別

  • 定義と範囲
    • 製薬およびバイオテクノロジー企業
    • 調査機関
    • その他
  • 最終用途別市場シェア
  • セグメントダッシュボード
  • 最終用途別の市場展望
    • 製薬およびバイオテクノロジー企業
    • 調査機関
    • その他

第6章 光学前臨床画像市場の予測と動向分析:国別

  • 国別市場シェア分析
  • 国別市場ダッシュボード
  • 地域別の市場スナップショット
  • 地域別の市場シェアと主要プレーヤー
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中南米
    • 中東・アフリカ
  • SWOT分析:要因別(政治&法務、経済、技術)
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中南米
    • 中東・アフリカ
  • 市場規模、予測、動向分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • タイ
    • 韓国
    • マレーシア
  • 中南米
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
  • 中東・アフリカ地域
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール

第7章 競合情勢

  • 主要市場参入企業による最近の動向、及び影響分析
  • 会社/競合の分類
  • ベンダー情勢
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America optical preclinical imaging market, by region, 2016 - 2027 (USD million)
  • Table 3 North America optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 4 North America optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 5 U.S. optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 6 U.S. optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 7 Canada optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 8 Canada optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 9 Europe optical preclinical imaging market, by region, 2016 - 2027 (USD million)
  • Table 10 Europe optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 11 Europe optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 12 U.K. optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 13 U.K. optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 14 Germany optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 15 Germany optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 16 Italy optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 17 Italy optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 18 Spain optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 19 Spain optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 20 France optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 21 France optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 22 Russia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 23 Russia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 24 Asia Pacific optical preclinical imaging market, by region, 2016 - 2027 (USD million)
  • Table 25 Asia Pacific optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 26 Asia Pacific optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 27 Japan optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 28 Japan optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 29 Japan others optical preclinical imaging market, by product, 2016 - 2027 (USD million)
  • Table 30 China optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 31 China optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 32 India optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 33 India optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 34 South Korea optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 35 South Korea optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 36 Thailand optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 37 Thailand optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 38 Malaysia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 39 Malaysia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 40 Latin America optical preclinical imaging market, by region, 2016 - 2027 (USD million)
  • Table 41 Latin America optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 42 Latin America optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 43 Brazil optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 44 Brazil optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 45 Mexico optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 46 Mexico optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 47 Argentina optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 48 Argentina optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 49 Columbia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 50 Columbia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 51 Middle East and Africa optical preclinical imaging market, by region, 2016 - 2027 (USD million)
  • Table 52 Middle East and Africa optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 53 Middle East and Africa optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 54 South Africa optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 55 South Africa optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 56 Saudi Arabia optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 57 Saudi Arabia optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 58 UAE optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 59 UAE optical preclinical imaging market, by end use, 2016 - 2027 (USD million)
  • Table 60 Qatar optical preclinical imaging market, by product type, 2016 - 2027 (USD million)
  • Table 61 Qatar optical preclinical imaging market, by end use, 2016 - 2027 (USD million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Optical preclinical imaging market, 2018
  • Fig. 14 Optical preclinical imaging market segmentation
  • Fig. 15 Optical preclinical imaging market trends
  • Fig. 16 Optical preclinical imaging market: market driver impact
  • Fig. 17 Optical preclinical imaging market: market restraint impact
  • Fig. 18 Penetration & Growth Prospect Mapping
  • Fig. 19 Optical preclinical imaging market - PESTLE Analysis
  • Fig. 20 Industry Analysis - Porter's
  • Fig. 21 Optical preclinical imaging market competitive landscape: Market position analysis (Based on product type, regional presence)
  • Fig. 22 Optical preclinical imaging market: Product Type outlook key takeaways
  • Fig. 23 Optical preclinical imaging market: Product Type movement analysis
  • Fig. 24 Optical preclinical imaging market: End use outlook, 2016 - 2027 (USD million)
  • Fig. 25 Regional marketplace, 2016 - 2027 (USD million)
  • Fig. 26 North America optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 27 U.S. optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 28 Canada optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 29 Europe optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 30 U.K. optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 31 Germany optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 32 France optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 33 Italy optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 34 Spain optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 35 Russia optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 36 Asia Pacific optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 37 Japan optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 38 China optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 39 India optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 40 South Korea optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 41 Thailand optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 42 Malaysia optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 43 Latin America optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 44 Brazil optical preclinical imaging market, 2016 - 2027 (USD MILLION)
  • FIG. 45 Mexico optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 46 Argentina optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 47 Columbia optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 48 Middle East and Africa optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 49 South Africa optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 50 Saudi Arabia optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 51 UAE optical preclinical imaging market, 2016 - 2027 (USD million)
  • Fig. 52 Qatar Optical preclinical imaging market, 2016 - 2027 (USD million)
目次
Product Code: GVR-4-68038-458-1

The global optical preclinical imaging market size is expected to reach USD 543.0 million by the end of 2027, expanding at a CAGR of 3.3%, according to a new report by Grand View Research, Inc. Increasing number of preclinical studies aimed to study and develop various effective therapeutics for different diseases is a major factor boosting the adoption of optical preclinical imaging systems.

For instance, in December 2018, Bugworks Research, a drug discovery startup based in India, received US$ 3 million grant from CARB-X, a Boston-based organization. The grant was offered to support the development of preclinical trail for novel molecules to fight antimicrobial resistance. Moreover, various researchers are engaged in finding novel ways to increase the reproducibility and robustness of preclinical cancer research with an aim to reduce the failure rate of oncology clinical trials. Optical imaging also allows cost-effective and high-throughput animal study as compared to small animal molecular imaging technologies, including PET and MRI systems.

Further key findings from the study suggest:

North America accounted for the largest share in 2019 owing to well-established research infrastructure, adoption of guidelines for preclinical research, product approvals, and higher number of drug development projects

Based on product type, in the device segment, bioluminescence captured the largest optical preclinical imaging market share in 2019 owing to high sensitivity and broad dynamic range as compared to other techniques for imaging animals used in various studies

The bioluminescence segment is expected to witness significant growth over the forecast period due to increasing adoption of bioluminescence technology to visualize and study disease processes in laboratory animals

By end use, the pharma and biotech companies segment accounted for the largest optical preclinical imaging market share in 2019 owing to increasing number of candidates in drug development studies and increasing focus on research and development for drug development and innovation

The research institutes segment is expected to witness the fastest growth during the forecast period owing to rising adoption of advanced optical imaging systems in the research institutes

Leading players operating in the market for optical preclinical imaging include Bruker; Perkin Elmer, Inc.; MR Solutions; BioTek Instruments, Inc.; Milabs B.V.; Fujifilm Holdings Corporation; Magnetic Insight, Inc.; MBF Bioscience; and Mediso Ltd.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. By Product type
    • 1.1.2. By End-use
    • 1.1.3. Country scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Optical Preclinical Imaging Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing number of pipeline drug candidates and drug development studies
      • 3.4.1.2. Government initiatives and grant approvals to support preclinical research
      • 3.4.1.3. Adoption of non-invasive imaging techniques focused on animal safety
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. Increasing adoption of alternative preclinical imaging technologies
  • 3.5. Optical Preclinical Imaging Analysis Tools
    • 3.5.1. Industry analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major deals & strategic alliances analysis
    • 3.5.4. Market entry strategies

Chapter 4. Optical Preclinical Imaging Market: By Product Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Device
    • 4.2.1. Fluorescence
    • 4.2.2. Bioluminescence
  • 4.3. Consumables
    • 4.3.1. Fluorescence
      • 4.3.1.1. Green fluorescent proteins
      • 4.3.1.2. Red fluorescent proteins
      • 4.3.1.3. Infrared dyes
      • 4.3.1.4. Others
    • 4.3.2. Bioluminescence
      • 4.3.2.1. Luciferins
      • 4.3.2.2. Proluciferins
      • 4.3.2.3. Coelenterazine
      • 4.3.2.4. Others
  • 4.4. Software
  • 4.5. By Product Type Market Share, 2019 & 2027
  • 4.6. Segment Dashboard
  • 4.7. Global Optical Preclinical Imaging by Product Type Outlook
    • 4.7.1. Device
      • 4.7.1.1. Device market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.1.2. Fluorescence
      • 4.7.1.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.1.3. Bioluminescence
      • 4.7.1.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 4.7.2. Consumables
      • 4.7.2.1. Consumables market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.2. Fluorescence
      • 4.7.2.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.2.2. Green fluorescent proteins
      • 4.7.2.2.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.2.3. Red fluorescent proteins
      • 4.7.2.2.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.2.4. Infrared dyes
      • 4.7.2.2.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.2.5. Others
      • 4.7.2.2.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.3. Bioluminescence
      • 4.7.2.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.3.2. Luciferins
      • 4.7.2.3.2.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.3.3. Proluciferins
      • 4.7.2.3.3.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.3.4. Coelenterazine
      • 4.7.2.3.4.1. Market estimates and forecast, 2016 - 2027 (USD Million)
      • 4.7.2.3.5. Luciferins
      • 4.7.2.3.5.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 4.7.3. Software
      • 4.7.3.1. Software market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 5. Optical Preclinical Imaging Market: By End-use Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Pharma and biotech companies
    • 5.1.2. Research institutes
    • 5.1.3. Others
  • 5.1. By End Use Market Share, 2019 & 2027
  • 5.2. Segment Dashboard
  • 5.3. Global Optical Preclinical Imaging by End-use Outlook
    • 5.3.1. Pharma and biotech companies
      • 5.3.1.1. Pharma and biotech companies market estimates and forecast, 2016 - 2027 (USD Million)
    • 5.3.2. Research institutes
      • 5.3.2.1. Research institutes market estimates and forecast, 2016 - 2027 (USD Million)
    • 5.3.3. Others
      • 5.3.3.1. Others market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 6. Optical Preclinical Imaging Market: Country Estimates & Trend Analysis

  • 6.1. Country Market Share Analysis, 2019 & 2027
  • 6.2. County Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2019
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East and Africa
  • 6.6. Market Size, & Forecasts, Volume and Trend Analysis, 2019 to 2027:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.7.2. U.S.
      • 6.7.2.1. U.S. market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.7.3. Canada
      • 6.7.3.1. Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.2. U.K.
      • 6.8.2.1. U.K. market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.3. Germany
      • 6.8.3.1. Germany market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.4. France
      • 6.8.4.1. France market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.5. Italy
      • 6.8.5.1. Italy market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.6. Spain
      • 6.8.6.1. Spain market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.8.7. Russia
      • 6.8.7.1. Russia market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.9.2. Japan
      • 6.9.2.1. Japan market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.9.3. China
      • 6.9.3.1. China market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.9.4. India
      • 6.9.4.1. India market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.9.5. Thailand
      • 6.9.5.1. Thailand market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.9.6. South Korea
      • 6.9.6.1. South Korea market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.9.7. Malaysia
      • 6.9.7.1. Malaysia market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.10. Latin America
    • 6.10.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.10.2. Brazil
      • 6.10.2.1. Brazil market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.10.3. Mexico
      • 6.10.3.1. Mexico market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.10.4. Argentina
      • 6.10.4.1. Argentina market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.10.5. Columbia
      • 6.10.5.1. Columbia market estimates and forecast, 2016 - 2027 (USD Million)
  • 6.11. Middle East & Africa
    • 6.11.1. Market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.11.2. South Africa
      • 6.11.2.1. South Africa market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.11.3. Saudi Arabia
      • 6.11.3.1. Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.11.4. UAE
      • 6.11.4.1. Kuwait market estimates and forecast, 2016 - 2027 (USD Million)
    • 6.11.5. Qatar
      • 6.11.5.1. Qatar market estimates and forecast, 2016 - 2027 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2019
    • 7.3.4. Bruker Corporation
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Procedure benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. PerkinElmer Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Procedure benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MR Solutions
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Procedure benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. BioTek Instruments, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Procedure benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Milabs B.V.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Procedure benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Magnetic Insight, Inc.
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Procedure benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. MBF Bioscience
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Procedure benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. FUJIFILM Holdings Corporation
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Procedure benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Mediso Ltd.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Procedure benchmarking
      • 7.3.12.4. Strategic initiatives